Showing results (2331-2340 of 2,572) with videos related to

Sort By:
Pageof 258
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkersCraig J Galbán, Mahaveer S Bhojani, Kuei C Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Development, Review, and Activation of Thoracic Oncology Investigator-Initiated TrialsDavid E Gerber, Claire R Wynters, Tanushree Prasad, et al.
Physical Review Letters|June 6, 2020
Attosecond Time-Domain Measurement of Core-Level-Exciton Decay in Magnesium OxideRomain Géneaux, Christopher J Kaplan, Lun Yue, et al.
Archives of Women'S Mental Health|July 7, 2021
A cross-sectional study of the relationship between CYP2D6 and CYP2C19 variations and depression symptoms, for women taking SSRIs during pregnancyCatriona Hippman, Caitlin Slomp, Emily Morris, et al.
Immunity|November 6, 2016
Deleting an Nr4a1 Super-Enhancer Subdomain Ablates Ly6Clow Monocytes while Preserving Macrophage Gene FunctionGraham D Thomas, Richard N Hanna, Neelakatan T Vasudevan, et al.
Cancer|April 16, 2013
Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patientsAndrew J Weickhardt, Robert C Doebele, W Thomas Purcell, et al.
Cancer Immunology Research|February 14, 2019
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung CancerSha Zhao, Shengxiang Ren, Tao Jiang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2021
Crizotinib in Patients With MET-Amplified NSCLCD Ross Camidge, Gregory A Otterson, Jeffrey W Clark, et al.
Pageof 258